Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The Registry MDS is an ongoing, observational study that has collected longitudinal data on diagnostics, demographics, clinical parameters, and health Care Interventions (HCI) from patients with MDS and therapy-related acute myeloid leukemia
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek powyżej 18 lat
- •Diagnoza zespołu mielodysplastycznego lub ostrej białaczki mieloidalnej
- •Zdolność i chęć do podpisania świadomej zgody
✗ Disqualifies
- •Wiek poniżej 18 lat
- •Brak możliwości lub chęci do podpisania zgody
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 11, 2026
- Sex
- No restrictions
Locations (1)
Aspasia Stamatoullas
Rouen, France
Trial contact
Fatiha CHERMAT, PhD
Pierre FENAUX, Pr
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/12/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.